Stay updated with breaking news from Texas Based Inform Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For El Monte-based clinical diagnostic testing company Fulgent Genetics Inc., the Covid testing surge that catapulted the company from $32 million in annual revenue to the doorstep of $1 billion in just two years has now all but ended.
Learn more about Fulgent Genetics’ share price tumbling as Covid test revenue falls and the company’s plans for a post-Covid testing strategy.
Learn more about Fulgent Genetics’ agreement to buy Texas testing firm Inform Diagnostics for $170 million, boosting its non-Covid testing business.